4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0001209191-15-053752
Director sold 250,000 shares at an average $26.68 ($6,670,678)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Troendle August J. Director | 2015-06-12 | Sale | −134,167 | $26.72 | $3,585,251 | 2,008,325 | I: show line 1 in the form |
| Troendle August J. Director | 2015-06-12 | Sale | −1,851 | $27.29 | $50,512 | 2,006,474 | I: show line 2 in the form |
| Troendle August J. Director | 2015-06-15 | Sale | −111,606 | $26.62 | $2,970,583 | 1,894,868 | I: show line 3 in the form |
| Troendle August J. Director | 2015-06-15 | Sale | −2,376 | $27.08 | $64,331 | 1,892,492 | I: show line 4 in the form |
| Open-market sales · 250,000 sh · avg $26.68 · $6,670,678 | |||||||
Loading xslF345X03/doc4.xml…